Bajaj HealthCare Limited Share Price NSE India S.E.

Equities

BAJAJHCARE

INE411U01027

Pharmaceuticals

Delayed NSE India S.E. 03:31:56 14/06/2024 pm IST 5-day change 1st Jan Change
315.6 INR +1.56% Intraday chart for Bajaj HealthCare Limited +6.68% -16.08%
Sales 2022 6.8B 81.42M Sales 2023 6.73B 80.63M Capitalization 8.41B 101M
Net income 2022 714M 8.55M Net income 2023 430M 5.15M EV / Sales 2022 1.76 x
Net Debt 2022 2.55B 30.51M Net Debt 2023 3.98B 47.6M EV / Sales 2023 1.84 x
P/E ratio 2022
13.2 x
P/E ratio 2023
19.5 x
Employees 1,173
Yield 2022
0.44%
Yield 2023
0.33%
Free-Float 25.05%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.56%
1 week+6.68%
Current month+9.22%
1 month+3.59%
3 months+1.61%
6 months-14.21%
Current year-16.08%
More quotes
1 week
295.00
Extreme 295
320.00
1 month
263.30
Extreme 263.3
320.00
Current year
263.30
Extreme 263.3
389.00
1 year
263.30
Extreme 263.3
513.40
3 years
257.45
Extreme 257.45
513.40
5 years
257.45
Extreme 257.45
513.40
10 years
257.45
Extreme 257.45
513.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 15/04/15
Chief Executive Officer 64 15/93/15
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 58 14/23/14
Chief Executive Officer 64 15/93/15
Director/Board Member 38 11/13/11
More insiders
Date Price Change Volume
14/24/14 315.6 +1.56% 194 328
13/24/13 310.7 +1.29% 105,454
12/24/12 306.8 -0.34% 107,547
11/24/11 307.8 +3.67% 226,923
10/24/10 296.9 +0.37% 38,319

Delayed Quote NSE India S.E., June 14, 2024 at 03:31 pm IST

More quotes
Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in activities of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), bulk drugs, branded and generic formulations. Its segments include Bulk Drugs and Formulations. It is focused on development, manufacturing and supply of amino acids, nutritional supplements and API for pharmaceutical, nutraceuticals and food industries. Its APIs include ascorbic acid, CH Base and its derivatives, citicoline sodium, carbamazepine, theobromine, ferrous ascorbate, doxofylline, oxcarbazepine, choline bitartrate and its derivatives, octenidine dihydrochloride, vildagliptin, ticagrelor, diosmin, hesperidin and others. Its FDFs include Cellin 500, Septran DS Tablet, Vitajaj C tables 500mg, Ticajaj 90 tablets, Ecojaj 75mg & 150mg, Deferajaj 400mg & 500mg, Vildajaj 50mg and Vildajaj M 50/500. It also offers Inositol Nicotinate and Magnesium L-Threonate.
More about the company